+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

High Content Screening Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4591626
  • Report
  • March 2020
  • Region: Global
  • 125 pages
  • Mordor Intelligence
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bio-Rad Laboratories Inc.
  • Biotek Instruments Inc.
  • Danaher Corporation
  • GE Healthcare
  • Merck KGaA
  • Perkinelmer Inc.
  • MORE
Under the conventional method of toxicity studies, large libraries are screened in search of potential drug candidates. This method is expensive, resource- and time-consuming, and has a low success rate. Consequently, high content screening (HCS) solutions for testing the potential toxicity of chemicals and complex substances are being adopted by pharmaceutical companies to improve in-vitro toxicity testing by reducing the time and cost. The need for cost containment in pharmaceutical R&D, advancements in informatics solutions and imaging instruments, and government funding and venture capital investments across developed markets are the major factors driving the growth of the high-content screening (HCS) market. The increasing number of contract research organizations providing HCS outsourcing services and application of HCS in personalized medicine, present significant growth opportunities in the market.

Key Market Trends

On the basis of Product Type, Instrument segment is believed to lead the market in future

Based on the product segment, the high content screening market is further segmented into instruments, consumables, software, others. Among all high content screening products, the instrument segment occupies the largest share of the market. The large share of this segment is attributed to advances in instrumentation and automation techniques and high prices of HCS instruments.

APAC region is expected to exhibit the highest growth rate

The high content screening market in APAC is expected to increase at the highest CAGR during the forecast period. Factors, such as increasing drug discovery research, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure are driving the growth of the HCS market in this region.

Competitive Landscape

For compound profiling applications, many pharmaceutical companies are partnering with contract research organizations to identify potential candidates for drug discovery. The HCS market is highly competitive in nature. The majority of large global players are based out of the United States and these players have expertise in other biotechnology/medical-technology verticals as well, which helps them in controlling the major market share, through a presence in the allied markets.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bio-Rad Laboratories Inc.
  • Biotek Instruments Inc.
  • Danaher Corporation
  • GE Healthcare
  • Merck KGaA
  • Perkinelmer Inc.
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Government Funding and Venture Capital Investments Across Developed Markets​
4.2.2 Increasing Applications of HCS in Life Science Research​
4.2.3 Advancements in Informatic Solutions and Imaging Systems​
4.3 Market Restraints
4.3.1 Lower Adoption of HCS Instruments Due to Their High Prices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Product
5.1.1 Instruments
5.1.1.1 Cell Imaging and Analysis Systems
5.1.1.2 Flow Cytometers
5.1.2 Consumables
5.1.2.1 Reagents and Assay Kits
5.1.2.2 Microplates
5.1.2.3 Other Consumables
5.1.3 Software
5.1.4 Others
5.2 Application
5.2.1 Primary and Secondary Screening
5.2.2 Target Identification and Validation
5.2.3 Toxicity Studies
5.2.4 Compound Profiling
5.2.5 Other Applications
5.3 End User
5.3.1 Pharmaceutical and Biotechnology Companies
5.3.2 Academic and Government Institutions
5.3.3 Contract Research Organisation
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 GE Healthcare
6.1.2 Danaher Corporation
6.1.3 Perkinelmer Inc.
6.1.4 Thermo Fisher Scientific Inc.
6.1.5 Becton, Dickinson and Company
6.1.6 Biotek Instruments Inc.
6.1.7 Bio-Rad Laboratories Inc.
6.1.8 Yokogawa Electric Corporation
6.1.9 Merck KGaA

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GE Healthcare
  • Danaher Corporation
  • Perkinelmer Inc.
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • Biotek Instruments Inc.
  • Bio-Rad Laboratories Inc.
  • Yokogawa Electric Corporation
  • Merck KGaA
Note: Product cover images may vary from those shown
Adroll
adroll